Key result
CARTs-based autonomic neuropathy linked to ~233% higher pre-liver transplant mortality.
Why the study?
Autonomic neuropathy in cirrhotic patients has been linked to cirrhosis-related complications and worse pre- or post-liver transplantation outcomes, but few studies exist with inconsistent results.
Does the presence of autonomic neuropathy predict mortality and complications in cirrhotic patients before and after liver transplantation?
Meta-Analysis (n=5,914)
Does the presence of autonomic neuropathy predict mortality and complications in cirrhotic patients before and after liver transplantation?
Absolute Event Rate: 20% vs 6%
p-value: p=0.01
Autonomic neuropathy diagnosed by cardiovascular autonomic reflex tests and heart rate variability, but not prolonged QTc, is a significant predictor of pre-liver transplantation mortality in cirrhotic patients.
May refine pre-liver transplant risk stratification in cirrhosis; supports autonomic neuropathy as a prognostic marker beyond QTc.
Background: Autonomic neuropathy (AN) in cirrhotic patients has been linked to a higher risk of cirrhosis-related complications and worse outcomes before, during or after liver transplantation (LT). However, only a few studies exist with inconsistent results. Methods: We searched for all articles published until September 2023 that described a diagnosis of AN based on cardiovascular autonomic reflex tests (CARTs), assessment of the rate-corrected QT interval (QTc), heart rate variability (HRV), and baroreflex sensitivity (BRS) tests, in order to evaluate the predictive role of AN in cirrhosis and/or peri-/post-LT prognosis. Results: Twenty-five studies were included: 5, 12, 9, and 1 study, respectively, assessed the predictive role of CARTs, prolonged QTc, HRV indices, and BRS in cirrhosis or peri-/post-LT prognosis. In CARTs-based analysis, the pre-LT pooled mortality rate was significantly higher in cirrhotics with AN compared to those without AN (20% vs. 6%; P=0.01). However, no difference was found between patients with and without pre-LT prolonged QTc in the pre-LT pooled mortality rates (41% vs. 18%; P=0.08), pooled peri-transplant risk of major complications (29% vs. 17%; P=0.08) or post-LT pooled mortality rates (15% vs. 12%; P=0.36). In HRV-based analysis, the standard deviation of normal-to-normal intervals was significantly lower in non-survivors, compared to survivors with cirrhosis: standardized mean difference -2.59, 95% confidence interval -4.75 to -0.43; P=0.04. Conclusions: The presence of CARTs- and HRV-based AN was a good predictor of mortality in the pre-LT setting. Preoperative prolonged QTc did not seem to be associated with the outcome before or after LT.
No takes yet. Share an insight, caveat, or question.
Antonia Neonaki (2024) conducted a meta-analysis in Cirrhosis (n=5,914). Cardiovascular autonomic reflex tests (CARTs)-based autonomic neuropathy vs. Without autonomic neuropathy was evaluated on Pre-liver transplantation mortality (p=0.01). Cardiovascular autonomic reflex tests (CARTs)-based autonomic neuropathy was associated with a significantly higher pre-liver transplantation pooled mortality rate compared to no autonomic neuropathy (20% vs. 6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: